BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16302002)

  • 1. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1.
    Walker GE; Antoniono RJ; Ross HJ; Paisley TE; Oh Y
    Oncogene; 2006 Mar; 25(13):1943-54. PubMed ID: 16302002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1.
    Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA
    Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis.
    Damon SE; Haugk KL; Swisshelm K; Quinn LS
    Exp Cell Res; 1997 Nov; 237(1):192-5. PubMed ID: 9417882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
    Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
    Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
    Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
    Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortisol enhances the expression of mac25/insulin-like growth factor-binding protein-related protein-1 in cultured osteoblasts.
    Pereira RC; Blanquaert F; Canalis E
    Endocrinology; 1999 Jan; 140(1):228-32. PubMed ID: 9886829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25).
    Ahmed S; Jin X; Yagi M; Yasuda C; Sato Y; Higashi S; Lin CY; Dickson RB; Miyazaki K
    FEBS J; 2006 Feb; 273(3):615-27. PubMed ID: 16420484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer.
    Chen Y; Pacyna-Gengelbach M; Ye F; Knösel T; Lund P; Deutschmann N; Schlüns K; Kotb WF; Sers C; Yasumoto H; Usui T; Petersen I
    J Pathol; 2007 Mar; 211(4):431-8. PubMed ID: 17236181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells.
    Ma Y; Lu B; Ruan W; Wang H; Lin J; Hu H; Deng H; Huang Q; Lai M
    Exp Mol Pathol; 2008 Oct; 85(2):141-5. PubMed ID: 18701096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine differentiation in lung cancer.
    Carey FA; Save VE
    J Pathol; 1997 May; 182(1):9-10. PubMed ID: 9227335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
    Gazdar AF; Kadoyama C; Venzon D; Park JG; Tsai CM; Linnoila RI; Mulshine JL; Ihde DC; Giaccone G
    J Natl Cancer Inst Monogr; 1992; (13):191-6. PubMed ID: 1327032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS; Kong G; Sun S; Liu D; El-Naggar AK; Khuri FR; Hong WK; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3796-802. PubMed ID: 12473592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.